Markets:

Overview

News

Currencies

International

Treasuries

Xilio Therapeutics, Inc. - Common Stock (NQ:XLO)

0.6800 +0.0110 (+1.64%)

Streaming Delayed Price Updated: 1:23 PM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xilio Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 05, 2023

Via Benzinga

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

September 27, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 20, 2023

Via Benzinga

Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer

September 05, 2023

Martin Huber, M.D., to leave Xilio Therapeutics and remain an advisor

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

September 05, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results

August 14, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officer

August 03, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Preliminary Clinical Data from Phase 1 Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Patients with Advanced Solid Tumors

May 25, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results

May 09, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 03, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates for the Fourth Quarter and Full Year 2022 Financial Results

March 02, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics to Present at Upcoming Investor Conferences

February 27, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit

February 16, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

February 02, 2023

From Xilio Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 26, 2023

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 26, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 21, 2022

On Wednesday, 152 stocks made new 52-week lows.

Via Benzinga

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

November 23, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) rose 68% to $0.5500 after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022 ↗

December 21, 2022

Via Benzinga

Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12

November 23, 2022

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results

November 09, 2022

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit

November 04, 2022

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 09, 2022

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.